Ixekizumab-induced cutaneous vasculitis: A rare challenge in the era of biologic therapies

Eine Yesid Benavides Tulcán, Sara Isabel Vanegas Arciniegas, Edgar Andrés Lozano Ponce · 2026

Read Ixekizumab-induced cutaneous vasculitis: A rare challenge in the era of biologic therapies by Eine Yesid Benavides Tulcán, Sara Isabel Vanegas Arciniegas, Edgar Andrés Lozano Ponce (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13396620.txt.

Description

Eine Yesid Benavides Tulcán and others tell of ixekizumab-linked skin vessel flare in a 2026 case tale. IL-17 block drugs treat skin scale and joint scale illness well, with known risks like yeast sores and gut flare, but vessel flare stays rare and dim.

A 74-year-old woman with high blood pressure and a smoke past had plaque and harsh joint scale illness. She broke out in vessel flare on ixekizumab, one of few such tales on IL-17 block drugs. Swift naming of this defense-linked flare shapes timely care and drug swaps. Prescribers gain a rare drug harm to watch for.

Catalog record

CREATOREine Yesid Benavides Tulcán, Sara Isabel Vanegas Arciniegas, Edgar Andrés Lozano Ponce
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE11 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13396620

Browse the full library · About the Tower of Babel